Investment analysts at StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Rating) in a report issued on Friday. The firm set a "sell" rating on the biotechnology company's stock.

Genocea Biosciences Price Performance

Shares of Genocea Biosciences stock opened at $0.00 on Friday. The company has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.01. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. Genocea Biosciences has a twelve month low of $0.00 and a twelve month high of $1.48. The stock has a market cap of $35,240.40, a price-to-earnings ratio of 0.00 and a beta of 1.61.

Genocea Biosciences Company Profile

(Get Rating)

Featured Articles

• Get a free copy of the StockNews.com research report on Genocea Biosciences (GNCA)
• Your Decision to Buy Palantir May Simply Be a Matter of Time
• Are Caterpillar and Deere Setting Up to Rally in 2023?
• Mullen Automotive Gets a Jolt as the I-GO Arrives in Europe
• Will The Sun Shine On These 3 Large-Cap Solar Stocks In 2023?
• Lucid Motors Faces a Reality That May Cloud a Bullish Perception

Receive News & Ratings for Genocea Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genocea Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.